Magnetic Silica-Coated Iron Oxide Nanochains as Photothermal Agents, Disrupting the Extracellular Matrix, and Eradicating Cancer Cells.

cancer cellular microenvironment collagen hyperthermia magnetic silica-coated iron oxide nanochains nanoparticles photothermal treatment

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
17 Dec 2019
Historique:
received: 30 10 2019
revised: 11 12 2019
accepted: 13 12 2019
entrez: 22 12 2019
pubmed: 22 12 2019
medline: 22 12 2019
Statut: epublish

Résumé

Cancerous cells and the tumor microenvironment are among key elements involved in cancer development, progression, and resistance to treatment. In order to tackle the cells and the extracellular matrix, we herein propose the use of a class of silica-coated iron oxide nanochains, which have superior magnetic responsiveness and can act as efficient photothermal agents. When internalized by different cancer cell lines and normal (non-cancerous) cells, the nanochains are not toxic, as assessed on 2D and 3D cell culture models. Yet, upon irradiation with near infrared light, the nanochains become efficient cytotoxic photothermal agents. Besides, not only do they generate hyperthermia, which effectively eradicates tumor cells in vitro, but they also locally melt the collagen matrix, as we evidence in real-time, using engineered cell sheets with self-secreted extracellular matrix. By simultaneously acting as physical (magnetic and photothermal) effectors and chemical delivery systems, the nanochain-based platforms offer original multimodal possibilities for prospective cancer treatment, affecting both the cells and the extracellular matrix.

Identifiants

pubmed: 31861146
pii: cancers11122040
doi: 10.3390/cancers11122040
pmc: PMC6966508
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Biomaterials. 2015 Jan;39:67-74
pubmed: 25477173
ACS Nano. 2015 Oct 27;9(10):9700-7
pubmed: 26394039
Anal Chem. 2013 Sep 17;85(18):8559-65
pubmed: 23919280
Cancers (Basel). 2019 Jul 30;11(8):null
pubmed: 31366108
J Am Chem Soc. 2012 Oct 31;134(43):17862-5
pubmed: 23083004
AJR Am J Roentgenol. 1989 Apr;152(4):771-5
pubmed: 2784260
Nutr Metab (Lond). 2013 Jan 08;10(1):2
pubmed: 23298332
Nanoscale Res Lett. 2012 Jan 16;7:77
pubmed: 22247975
Cancer Lett. 2011 Dec 8;311(2):131-40
pubmed: 21840122
Nano Lett. 2010 Sep 8;10(9):3318-23
pubmed: 20684528
J Membr Biol. 2012 Sep;245(9):565-71
pubmed: 22797942
Toxicol Lett. 2006 May 25;163(2):109-20
pubmed: 16289865
Cell Transplant. 2012;21(4):679-91
pubmed: 22080748
J Neurooncol. 2006 May;78(1):7-14
pubmed: 16314937
Chemosphere. 2009 Aug;76(8):1023-7
pubmed: 19477482
Chem Soc Rev. 2016 May 3;45(9):2440-57
pubmed: 26862602
Sci Rep. 2018 Jan 9;8(1):185
pubmed: 29317706
J Am Chem Soc. 2010 Nov 3;132(43):15351-8
pubmed: 20942456
Curr Protoc Immunol. 2015 Nov 02;111:A3.B.1-A3.B.3
pubmed: 26529666
Eur Biophys J. 2002 May;31(2):118-25
pubmed: 12012115
ACS Nano. 2014 May 27;8(5):4268-83
pubmed: 24738788
Nat Protoc. 2006;1(5):2315-9
pubmed: 17406473
Am J Pathol. 1995 Jan;146(1):3-15
pubmed: 7856735
Acc Chem Res. 2011 Oct 18;44(10):936-46
pubmed: 21612199
Mol Pharm. 2008 Mar-Apr;5(2):316-27
pubmed: 18217714
Virchows Arch Pathol Anat Physiol Klin Med. 1960;333:421-65
pubmed: 13765553
ACS Nano. 2013 May 28;7(5):3939-52
pubmed: 23634880
Curr Med Chem. 2017;24(5):454-469
pubmed: 27528059
Contrast Media Mol Imaging. 2013 Mar-Apr;8(2):193-203
pubmed: 23281292
Invest Radiol. 2002 Apr;37(4):167-77
pubmed: 11923639
J Extracell Vesicles. 2015 May 14;4:27066
pubmed: 25979354
Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):911-6
pubmed: 22203958
ACS Nano. 2015 Aug 25;9(8):7925-39
pubmed: 26168364
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4044-4053
pubmed: 30760598
Biomaterials. 2008 Aug;29(22):3161-74
pubmed: 18455232
Biofabrication. 2017 May 11;9(2):025017
pubmed: 28493850
J Nanobiotechnology. 2013;11 Suppl 1:S7
pubmed: 24564857
Pharmacol Res. 2017 Dec;126:123-137
pubmed: 28720518
Biomaterials. 2013 May;34(16):4078-4088
pubmed: 23465836
Tissue Eng Part A. 2010 Oct;16(10):3199-206
pubmed: 20528673
J RNAi Gene Silencing. 2013 Mar 15;9:479-85
pubmed: 23946765
NMR Biomed. 2006 Aug;19(5):581-92
pubmed: 16673357
Spectrochim Acta A Mol Biomol Spectrosc. 2011 Dec;83(1):398-405
pubmed: 21925929

Auteurs

Jelena Kolosnjaj-Tabi (J)

Institute of Pharmacology and Structural Biology, 205 Route de Narbonne, 31400 Toulouse, France.

Slavko Kralj (S)

Department for Materials Synthesis, Jožef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia.
Faculty of Pharmacy, University of Ljubljana, Askerceva cesta 7, 1000 Ljubljana, Slovenia.

Elena Griseti (E)

Institute of Pharmacology and Structural Biology, 205 Route de Narbonne, 31400 Toulouse, France.

Sebastjan Nemec (S)

Department for Materials Synthesis, Jožef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia.
Faculty of Pharmacy, University of Ljubljana, Askerceva cesta 7, 1000 Ljubljana, Slovenia.

Claire Wilhelm (C)

Laboratoire Matière et Systèmes Complexes (MSC), UMR 7057, Bâtiment Condorcet, Université Paris Diderot, 10 rue Alice Domon et Léonie Duquet, 75205 Paris, France.

Anouchka Plan Sangnier (A)

Faculty of Pharmacy, University of Ljubljana, Askerceva cesta 7, 1000 Ljubljana, Slovenia.

Elisabeth Bellard (E)

Institute of Pharmacology and Structural Biology, 205 Route de Narbonne, 31400 Toulouse, France.

Isabelle Fourquaux (I)

Centre de Microscopie Electronique Appliquée à la Biologie (CMEAB), Faculté de Médecine Rangueil, 133 Route de Narbonne, 31400 Toulouse, France.

Muriel Golzio (M)

Institute of Pharmacology and Structural Biology, 205 Route de Narbonne, 31400 Toulouse, France.

Marie-Pierre Rols (MP)

Institute of Pharmacology and Structural Biology, 205 Route de Narbonne, 31400 Toulouse, France.

Classifications MeSH